| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/20/2009 | WO2009004146A3 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 08/20/2009 | US20090209729 Recombinant chemokine-antigen vaccine |
| 08/20/2009 | US20090209658 Embolic compositions |
| 08/20/2009 | US20090209655 Isoflavone metabolites |
| 08/20/2009 | US20090209648 Phenylacetic Acid Derivatives |
| 08/20/2009 | US20090209641 Pharmaceutical composition for administration by injection |
| 08/20/2009 | US20090209629 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications |
| 08/20/2009 | US20090209606 Cancer Treatments |
| 08/20/2009 | US20090209596 Oxazole Hydroxamic Acid Derivatives and Use Thereof |
| 08/20/2009 | US20090209595 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209594 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209568 Spiro [Benzopyran] or Spiro [Benzofuran] Derivatives Which Inhibit the Sigma Receptor |
| 08/20/2009 | US20090209566 Spirocyclic Compounds |
| 08/20/2009 | US20090209559 Pharmaceutical compounds |
| 08/20/2009 | US20090209555 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 08/20/2009 | US20090209554 Thiazoliums as transketolase inhibitors |
| 08/20/2009 | US20090209537 Aurora inhibitors |
| 08/20/2009 | US20090209534 Novel compounds and use of tetrahydropyridopyridothiophenes |
| 08/20/2009 | US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/20/2009 | US20090209523 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) |
| 08/20/2009 | US20090209522 Heterocyclic Non-Peptide GNRH Antagonists |
| 08/20/2009 | US20090209521 Inhibition of VEGF Translation |
| 08/20/2009 | US20090209520 2 -oxybenzamide derivatives as parp inhibitors |
| 08/20/2009 | US20090209508 Compounds for Photochemotherapy |
| 08/20/2009 | US20090209507 15-O-Desmethylmacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies |
| 08/20/2009 | US20090209496 Methods and compositions for enhancing the efficacy of rtk inhibitors |
| 08/20/2009 | US20090209495 Use of edg receptor binding agents in cancer |
| 08/20/2009 | US20090209493 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor |
| 08/20/2009 | US20090209489 Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system |
| 08/20/2009 | US20090209485 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides |
| 08/20/2009 | US20090209482 Azacytidine analogues and uses thereof |
| 08/20/2009 | US20090209477 Azacytidine analogues and uses thereof |
| 08/20/2009 | US20090209475 Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same |
| 08/20/2009 | US20090209466 Peptides with anti-proliferative activity |
| 08/20/2009 | US20090209450 MicroRNA Fingerprints During Human Megakaryocytopoiesis |
| 08/20/2009 | US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/20/2009 | US20090209034 Tumour rejection antigens |
| 08/20/2009 | US20090209006 Taci-immunoglobulin fusion proteins |
| 08/20/2009 | US20090208972 Cytotoxic protein and utlization thereof |
| 08/20/2009 | US20090208969 Polynucleotides and Polypeptides Encoding Receptors |
| 08/20/2009 | US20090208597 Heat processed vegetabilic fiber preparation and its use as inhibitor of the effects of carcinogenic substances in humans or animals |
| 08/20/2009 | US20090208590 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 08/20/2009 | US20090208580 Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| 08/20/2009 | US20090208537 Anti-Neovasculature Preparations for Cancer |
| 08/20/2009 | US20090208534 Attenuated salmonella as a delivery system for sirna-based tumor therapy |
| 08/20/2009 | US20090208524 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 08/20/2009 | US20090208518 Immunogenic peptides for the treatment of prostate and breast cancer |
| 08/20/2009 | US20090208514 Method of diagnosing esophageal cancer |
| 08/20/2009 | US20090208505 Mutations of the pik3ca gene in human cancers |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208500 Method of producing antibodies with improved function |
| 08/20/2009 | US20090208498 Genetic Products Differentially Expressed In Tumors And The Use Thereof |
| 08/20/2009 | US20090208493 Compounds and methods for the selective inhibition of ABCB1, ABCC1 and ABCG2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput flow cytometry assay to detect selective inhibitors |
| 08/20/2009 | US20090208489 Antibodies That Bind OV064 and Methods of Use Therefor |
| 08/20/2009 | US20090208486 Pharmaceutical composition comprising cxcr3 inhibitor |
| 08/20/2009 | US20090208476 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 08/20/2009 | US20090208475 Mina53 assays |
| 08/20/2009 | US20090208468 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| 08/20/2009 | US20090208466 Ink-jet printing of tissues |
| 08/20/2009 | US20090208431 preparing a non-staining mixture by mixing a turmeric extract with an acidity berry extract in a ratio from 1:1 parts to 1:20 parts (v/v); for cosmetic, protective, and healing purposes without staining skin or clothing yellow |
| 08/20/2009 | US20090208416 Monoclonal antibodies against nkg2a |
| 08/20/2009 | US20090208411 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 08/20/2009 | US20090208410 Ed-b fibronectin as stratification marker for anti-tumor drugs |
| 08/20/2009 | DE10329874B4 Tajixanthonhydrat und dessen Verwendung zur Behandlung von Tumorerkrankungen Tajixanthonhydrat and its use for the treatment of tumor diseases |
| 08/20/2009 | DE102008010363A1 Sgk1 als therapeutisches und diagnostisches Target für karzinomatöse Erkrankungen Sgk1 as therapeutic and diagnostic target for cancerous diseases |
| 08/20/2009 | DE102008009609A1 Substituierte 4-(Indol-3-yl)chinazoline und deren Verwendung und Herstellung Substituted 4- (indol-3-yl) quinazolines and their use and production |
| 08/20/2009 | CA2747133A1 Uses of modified elr-cxc chemokine g31p |
| 08/20/2009 | CA2715658A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 08/20/2009 | CA2715460A1 Continuous cell programming devices |
| 08/20/2009 | CA2715326A1 Doxorubicin adjuvants to reduce toxicity and methods for using the same |
| 08/20/2009 | CA2715294A1 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 08/20/2009 | CA2715293A1 Selective agonist of toll-like receptor 3 |
| 08/20/2009 | CA2714657A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | CA2714445A1 Treatment of metastatic stage prostate cancer with degarelix |
| 08/20/2009 | CA2714444A1 Method of treating prostate cancer with the gnrh antagonist degarelix |
| 08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
| 08/20/2009 | CA2713112A1 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide |
| 08/19/2009 | EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 08/19/2009 | EP2090654A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090585A1 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm |
| 08/19/2009 | EP2090577A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 08/19/2009 | EP2090575A1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090322A1 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 08/19/2009 | EP2090306A1 Pharmaceutical compositions comprising N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 08/19/2009 | EP2090305A1 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
| 08/19/2009 | EP2090304A2 Use of sugar phosphates, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycose-enzyme complex, the malate aspartate shuttle and/or transaminases |
| 08/19/2009 | EP2090177A1 Food products having enhanced cocoa polyphenol content |
| 08/19/2009 | EP2089514A1 Cancerous disease modifying antibodies |
| 08/19/2009 | EP2089433A2 Therapy targeting cathepsin s |
| 08/19/2009 | EP2089423A1 Antigen specific multi epitope vaccines |
| 08/19/2009 | EP2089416A1 Depsipeptides and their therapeutic use |
| 08/19/2009 | EP2089415A1 Depsipeptides and their therapeutic use |
| 08/19/2009 | EP2089409A1 Compound having inhibitory activity on a rho-gtpase cell protein, a process for obtaining the same, pharmaceutical compositions comprision thereof and a method for the treatment of a rho-gtpase cell protein-mediated condition |
| 08/19/2009 | EP2089404A1 Crystalline forms of zoledronic acid |